Enforcement record

Voluntary Recall disclosure naming デンカ株式会社

デンカ株式会社 (Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices)

This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.

Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical DevicesMinistry of Health, Labour and WelfareGovernment disclosure8 November 2021

Action type

Voluntary Recall

Law

Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices

Authority

Ministry of Health, Labour and Welfare

Action date

8 November 2021

RegBase evidence report

Japanese public-record enforcement check

Saveable record of the published action, regulator source, source status, and review notes for internal compliance files.

Report ID: RB-EN-ENFORCEMENT-OTHER-DENKA-20211-202608041847
Generated at: 5 August 2026 at 03:47
Record URL: https://regbase.jp/en/enforcement/other-denka-20211108

1. Review Summary

Disclosure name	デンカ株式会社	Corporate Number	Not stated in the disclosure
Enforcement record	1 record	Other confirmed records for this company	Outside this report's scope
Action date	8 November 2021	Authority	Ministry of Health, Labour and Welfare
Law	Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices	Action type	Voluntary Recall
Source status	Preserved public-source archive recorded

This report summarizes public Japanese government disclosure data held by RegBase. It is not a credit score, sanctions conclusion, legal opinion, or adverse-media determination. Confirm important decisions against the linked official Japanese source.

2. Published Information

Published name	デンカ株式会社

3. Enforcement Record

Target name in disclosure	デンカ株式会社
Authority	Ministry of Health, Labour and Welfare (厚生労働省)
Law / action type	Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices / Voluntary Recall
Action / announcement date	Action: 8 November 2021 / Announcement: 10 April 2026
English summary	Regarding the antigen rapid test kits, under the distribution project based on the Ministry of Health, Labour and Welfare's notice titled 'Distribution of antigen rapid test kits to medical institutions, elderly care facilities, etc.' dated June 9, 2021, a total of 1,201,300 units have been distributed out of the 1,300,000 units mentioned above. For the distributed antigen rapid test kits, the Ministry of Health, Labour and Welfare and others have sent distribution destination lists to Denka Corporation, and under Denka's responsibility, including cost burden, the exchange of the new antigen rapid test kits is planned to be carried out.
Original Japanese text	抗原簡易キットについては、「医療機関・高齢者施設等への抗原簡易キット配布事業について」（令和３年６月９日付厚生労働省新型コロナウイルス感染症対策推進本部事務連絡）に基づく配布事業において、上記1,300,000個のうち1,201,300個が配布されております。配布済みの抗原簡易キットについては、厚生労働省等からデンカ株式会社に対し配布先リストの送付等を行い、費用負担も含めデンカ株式会社の責任の下で新しい抗原簡易キットの交換が行われる予定です。
Official source	https://www.mhlw.go.jp/stf/newpage_22115.html
Source archive	https://kiroku.today/a/dedeb0cbf3hgrjap
Extraction / evidence timestamps	Extracted: 25 April 2026 at 09:20 / Evidence checked: 25 April 2026 at 09:20 / Archive captured: 12 July 2026 at 16:21

4. Business Location and Permit Details

No additional structured business-location or permit fields are recorded for this disclosure.

5. Other Confirmed Records for This Company

This report covers the single government disclosure shown on this page.

Reviewer Notes

Reviewer		Team / company
Review purpose
Additional notes

□ Official source URL or archived source was checked.
□ Corporate Number, address, or other identifiers were reviewed to avoid confusing similarly named entities.
□ This document is understood as a public-record evidence file, not a credit decision or legal opinion.

Current page: Enforcement record

This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.

Free report

Save the disclosure record naming デンカ株式会社

Includes the published name, regulator, governing law, source links, archive status, and reviewer note fields for internal due-diligence files.

Preserved evidence by Kiroku

Review the preserved source for デンカ株式会社

Open the preserved public source with its capture time, original artifact, available verification data, and downloadable evidence pack.

Open preserved source and evidence pack

For developers: JSON integration details

You do not need this for normal browsing. Use it only when integrating this enforcement record into an internal tool or AI workflow.

/api/v1/enforcements?company=%E3%83%87%E3%83%B3%E3%82%AB%E6%A0%AA%E5%BC%8F%E4%BC%9A%E7%A4%BE&limit=10

Open JSON Specs

Action summary

Company: デンカ株式会社Japanese only
Original: デンカ株式会社
Governing law: Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
医薬品医療機器等法
Action type: Voluntary Recall
自主回収
Action date: 8 November 2021
Issuing authority: Ministry of Health, Labour and Welfare
厚生労働省
Industry context: 医薬品・医療機器

Violation

Machine-translated summary — verify against original

Regarding the antigen rapid test kits, under the distribution project based on the Ministry of Health, Labour and Welfare's notice titled 'Distribution of antigen rapid test kits to medical institutions, elderly care facilities, etc.' dated June 9, 2021, a total of 1,201,300 units have been distributed out of the 1,300,000 units mentioned above. For the distributed antigen rapid test kits, the Ministry of Health, Labour and Welfare and others have sent distribution destination lists to Denka Corporation, and under Denka's responsibility, including cost burden, the exchange of the new antigen rapid test kits is planned to be carried out.

Show original Japanese text

抗原簡易キットについては、「医療機関・高齢者施設等への抗原簡易キット配布事業について」（令和３年６月９日付厚生労働省新型コロナウイルス感染症対策推進本部事務連絡）に基づく配布事業において、上記1,300,000個のうち1,201,300個が配布されております。配布済みの抗原簡易キットについては、厚生労働省等からデンカ株式会社に対し配布先リストの送付等を行い、費用負担も含めデンカ株式会社の責任の下で新しい抗原簡易キットの交換が行われる予定です。

Compliance context

Context needed

This is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.

Japanese regulatory disclosure under Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices.

Review the original Japanese source and determine relevance to your counterparty-risk workflow.

This context is an operational aid for review workflows, not a credit opinion or legal conclusion.

Evidence pack

Original Ministry of Health, Labour and Welfare source (Japanese)Open preserved source and evidence pack

Extracted at: 2026-04-25T00:20:41.156+00:00
Evidence checked: 2026-04-25T00:20:41.156+00:00
Archive captured: 2026-07-12T07:21:36.06795+00:00

Show audit JSON

{
  "record": {
    "id": "e30cfd89-3c25-47cb-8453-bfafe7a20778",
    "url": "https://regbase.jp/en/enforcement/other-denka-20211108",
    "company_name_original": "デンカ株式会社",
    "company_name_registry": null,
    "corporate_number": null,
    "law": {
      "ja": "医薬品医療機器等法",
      "en": "Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices"
    },
    "action_type": {
      "ja": "自主回収",
      "en": "Voluntary Recall"
    },
    "authority": {
      "ja": "厚生労働省",
      "en": "Ministry of Health, Labour and Welfare"
    }
  },
  "entity_match": {
    "status": "unresolved",
    "confidence": 85,
    "method": "nta_strict_name_nationally_unique",
    "method_label": "nta_strict_name_nationally_unique",
    "notes": "NTA full-download lookup found a nationally unique exact registered-name candidate (デンカ株式会社). No Corporate Number was present in the disclosure, so this remains a likely match."
  },
  "review": {
    "status": "unreviewed",
    "label": "Machine extracted"
  },
  "compliance_context": {
    "severity": "Context needed",
    "actionMeaning": "This is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.",
    "practicalNote": "Review the original Japanese source and determine relevance to your counterparty-risk workflow.",
    "lawContext": "Japanese regulatory disclosure under Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices."
  },
  "evidence": {
    "recordUrl": "https://regbase.jp/en/enforcement/other-denka-20211108",
    "officialSourceUrl": "https://www.mhlw.go.jp/stf/newpage_22115.html",
    "officialDocumentUrl": null,
    "archiveUrl": "https://kiroku.today/a/dedeb0cbf3hgrjap",
    "archivedSourceUrl": "https://www.mhlw.go.jp/stf/newpage_22115.html",
    "archiveCapturedAt": "2026-07-12T07:21:36.06795+00:00",
    "extractedAt": "2026-04-25T00:20:41.156+00:00",
    "translatedAt": "2026-05-01T07:09:02.249+00:00",
    "evidenceCheckedAt": "2026-04-25T00:20:41.156+00:00",
    "generatedAt": "2026-08-04T18:47:30.727Z"
  },
  "limitations": [
    "RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
    "English summaries are provided for reference. The original Japanese source is authoritative.",
    "Possible or unresolved entity matches should be manually verified before use in a decision."
  ]
}

The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.

Language

日本語版を見る (Japanese)

About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.